These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 6094884)

  • 1. [Pharmacological studies on drugs inhibiting platelets aggregation].
    Tanaka K
    Rinsho Ketsueki; 1984 Jul; 25(7):992-7. PubMed ID: 6094884
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative effect of chlorpromazine, imipramine and papaverine on the blood platelet function].
    Bartel' V; Gluza E; Markvardt F
    Farmakol Toksikol; 1976; 39(3):296-301. PubMed ID: 193725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibitory effects of chlorpromazine and imipramine on platelet aggregation.
    Ishigooka J; Tanaka K; Suzuki Y; Katori M; Miura S
    Int Pharmacopsychiatry; 1980; 15(5):270-80. PubMed ID: 7263149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
    Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
    Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimucytin: a collagen-like aggregating inducer isolated from Trimeresurus mucrosquamatus snake venom.
    Teng CM; Ko FN; Tsai IH; Hung ML; Huang TF
    Thromb Haemost; 1993 Mar; 69(3):286-92. PubMed ID: 8470053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of thromboxane antagonist EP 045 on platelet aggregation.
    Jones RL; Wilson NH; Armstrong RA; Peesapati V; Smith GM
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():345-50. PubMed ID: 6303074
    [No Abstract]   [Full Text] [Related]  

  • 7. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
    Mevkh AT; Basevich VV; Varfolomeev SD
    Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggregation and inhibition of rat platelets, and the formation of endoperoxide metabolites.
    Hwang DH
    Prostaglandins Med; 1980 Sep; 5(3):163-73. PubMed ID: 7413850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the influence of nitroglycerin on the synthesis of prostaglandins and thromboxane A2 and on platelet aggregation.
    Rettkowski W; Pönicke K; Block HU; Giessler C; Dunemann A; Zehl U; Förster W
    Arzneimittelforschung; 1982; 32(3):194-200. PubMed ID: 6805480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of platelet anti-aggregation effect of several anti-inflammatory agents].
    Migne J; Santonja R; Kunz S
    Sem Hop; 1983 Dec; 59(46):3197-203. PubMed ID: 6318340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of thromboxane A2 and aorta-contracting activity from platelets stimulated with modified C-reactive protein.
    Simpson RM; Prancan A; Izzi JM; Fiedel BA
    Immunology; 1982 Sep; 47(1):193-202. PubMed ID: 7118160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy.
    Horn EH; Hardy E; Cooper J; Heptinstall S; Rubin PC
    Thromb Haemost; 1996 Feb; 75(2):346-51. PubMed ID: 8815588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of prostacyclin and thromboxane A2 in the regulation of platelet behaviour.
    Moncada S
    Mater Med Pol; 1980; 12(3):207-12. PubMed ID: 7019591
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of a single Ditazole dose on platelet aggregation and prostaglandin formation.
    Prisco D; Bartoletti A; Lombardi A
    Int J Clin Pharmacol Res; 1984; 4(2):129-36. PubMed ID: 6147319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane-mediated activation of platelets and enhancement of platelet uptake onto collagen-coated glass or deendothelialized rabbit aorta. Comparative effects of a thromboxane antagonist (EPO45) and a thromboxane synthetase inhibitor (dazoxiben).
    Menys VC; Davies JA
    Lab Invest; 1984 Feb; 50(2):184-9. PubMed ID: 6546403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis.
    Aiken JW; Shebuski RJ; Miller OV; Gorman RR
    J Pharmacol Exp Ther; 1981 Nov; 219(2):299-308. PubMed ID: 6270303
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclic-AMP agonists inhibit antiphospholipid/beta2-glycoprotein I induced synthesis of human platelet thromboxane A2 in vitro.
    Opara R; Robbins DL; Ziboh VA
    J Rheumatol; 2003 Jan; 30(1):55-9. PubMed ID: 12508390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Function of prostaglandins in platelet aggregation].
    Sun QW
    Sheng Li Ke Xue Jin Zhan; 1980 Feb; 11(2):137-42. PubMed ID: 7001620
    [No Abstract]   [Full Text] [Related]  

  • 19. A major role of ADP in thromboxane transfer experiments: studies in patients with platelet secretion defects.
    Rao AK; Willis J; Holmsen H
    J Lab Clin Med; 1984 Jul; 104(1):116-26. PubMed ID: 6429260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of platelet aggregation and adenosine 3':5'-monophosphate on the synthesis of thromboxane B2 in human platelets.
    Lindgren JA; Claesson HE; Kindahl H; Hammarström S
    Adv Prostaglandin Thromboxane Res; 1980; 6():275-81. PubMed ID: 6247886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.